Skip to main content

Month: May 2024

APA Announces over $700 Million in Asset Sales from Two Transactions for Non-core Texas Properties

HOUSTON, May 20, 2024 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) announced today the sale of non-core producing properties by Apache Corporation and certain of its subsidiaries in two separate transactions with aggregate proceeds of more than $700 million, prior to customary closing adjustments. Combined, the properties represent estimated net production in the first-quarter 2024 of 13,000 barrels of oil equivalent per day (Mboe/d), of which just over one-third is oil. Proceeds from these asset sales will be used primarily to reduce nearer-term borrowings. Closing for both sales is expected early in the third-quarter 2024. “These transactions are consistent with our active management of the portfolio, and we will continue to look for opportunities to exit assets that are unlikely to compete for capital within our portfolio...

Continue reading

Gaming and Leisure Properties, Inc. Declares Second Quarter 2024 Cash Dividend of $0.76 Per Share

WYOMISSING, Pa., May 20, 2024 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (the “Company”) announced today that the Company’s Board of Directors has declared the second quarter 2024 cash dividend of $0.76 per share of its common stock. The dividend is payable on June 21, 2024 to shareholders of record on June 7, 2024. The second quarter 2023 cash dividend was $0.72 per share of the Company’s common stock. While the Company intends to pay regular quarterly cash dividends for the foreseeable future, all subsequent dividends will be reviewed quarterly and declared by the Board of Directors at its discretion. About Gaming and Leisure Properties GLPI is engaged in the business of acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements, pursuant...

Continue reading

Zoom Video Communications Reports Financial Results for the First Quarter of Fiscal Year 2025

First quarter total revenue of $1,141.2 million, up 3.2% year over year as reported and 3.5% in constant currency First quarter Enterprise revenue of $665.7 million, up 5.3% year over year First quarter GAAP operating margin of 17.8% and non-GAAP operating margin of 40.0% First quarter operating cash flow of $588.2 million, up 40.6% year over year Repurchased approximately 2.4 million shares of common stockSAN JOSE, Calif., May 20, 2024 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM), today announced financial results for the first fiscal quarter ended April 30, 2024. “In Q1, we continued to integrate AI across our platform including Zoom Contact Center and Zoom Workplace, our AI-powered collaboration platform that provides customers the ability to reimagine teamwork by streamlining communications, increasing...

Continue reading

TMTG Reports First Quarter 2024 Results

~ Completed the Business Combination with Digital World Acquisition Corp., Successfully Debuted as Public Company, and Now Has Over 621,000 Retail Shareholders. ~ ~ Commenced Trading on Nasdaq, Under Symbol DJT on March 26, 2024 ~ ~ Company Has Sufficient Working Capital as a Result of a Going Public Event ~ ~ Signs First Contracts for Deployment of its TV Streaming Platform ~ SARASOTA, Fla., May 20, 2024 (GLOBE NEWSWIRE) — Trump Media and Technology Group Corp. (Nasdaq: DJT) (“TMTG” or the “Company”), operator of the social media platform Truth Social, is announcing financial results for the fiscal quarter ending on March 31, 2024, and will also file its 10-Q with the Securities and Exchange Commission (the “SEC”) today. TMTG’s quarterly report and financials were reviewed by Semple, Marchal & Cooper, LLP, which the Company...

Continue reading

Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update

– Presented preclinical data demonstrating abscopal immune effect in pancreatic murine tumor models at ESTRO 2024 Congress in Glasgow – – First patient with liver metastases treated in a feasibility and safety study of Alpha DaRT at the McGill University Health Center in Montreal, Canada – – Patient recruitment for ReSTART U.S. multi-center pivotal trial and for pancreatic cancer feasibility and safety studies in Canada and Israel currently ongoing – – Cash, cash equivalents, deposits & restricted deposits balance of $80.7 million with runway of at least two years – JERUSALEM, May 20, 2024 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™,...

Continue reading

Nokia Corporation: Repurchase of own shares on 20.05.2024

Nokia CorporationStock Exchange Release20 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 20.05.2024 Espoo, Finland – On 20 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 370,393 3.56CEUX – –BATE – –AQEU – –TQEX – –Total 370,393 3.56* Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation...

Continue reading

ZW Data Action Announces Receipt of Nasdaq Non-Compliance Notice

BEIJING, China, May 20, 2024 (GLOBE NEWSWIRE) — ZW Data Action Technologies Inc. (NASDAQ: CNET) (“ZW Data Action” or the “Company”), an integrated online advertising, precision marketing, data analytics and other value-added services provider serving enterprise clients, today announced that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on May 17, 2024 notifying the Company that due to the Company’s failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the “Form 10-Q”), with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic...

Continue reading

Saia Continues Expansion with New Terminal

The new Pennsylvania location brings the number of facilities the carrier operates in the state to seven JOHNS CREEK, Ga., May 20, 2024 (GLOBE NEWSWIRE) — Saia Inc. (NASDAQ: SAIA) announced that Saia LTL Freight’s newest Pennsylvania terminal, in Reading, commenced operations today. The facility will provide customers with more direct shipping points across the Northeast and beyond. “We are excited to be a part of the Reading community, which is a new market for us,” said Vice President of Operations, East Jared Mull. “The local economy is growing, so we are happy to help facilitate added growth by providing shipping services as well as jobs. This location is also important as it will offer increased flexibility and better overall service for Saia customers.” Thus far this year, Saia has opened new facilities in Montana, New Jersey,...

Continue reading

“NASDAQ JAPAN IR EVENT” to Be Held at Nasdaq MarketSite on June 20, 2024

Discover the appeal of Japanese companies listed in the U.S.Japan IR Event at NadaqJapan IR Event at NadaqJapan IR Event at NadaqJapan IR Event at NadaqNEW YORK, May 20, 2024 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (“MEDIROM”, the “Company”), today announced it will participate in a “NASDAQ JAPAN IR EVENT” to be held at Nasdaq MarketSite in Times Square on June 20, 2024. Five companies are currently expected to join this event (including one private company), and we will share information about the attractive nature of the Japanese market with a global audience. PurposeIn December 2020, the Company became the first Japanese company in 21 years to list on Nasdaq. Today, the number of Japanese companies listed on Nasdaq has increased...

Continue reading

Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference

KRRO-110 showed sustained editing efficiency of approximately 60% and increased total alpha-1 antitrypsin (AAT) protein levels to greater than 60uM at week 13 in an in vivo genetic Alpha-1 Antitrypsin Deficiency (AATD) mouse model KRRO-110 showed 35µM of M-AAT one week post the first dose, with 0µM of M-AAT at baseline, increasing to 45µM of M-AAT at week 13CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) —  Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases, is presenting new preclinical data demonstrating the specificity and the completion of a genetic mouse study and sustained editing activity for KRRO-110, its development candidate for the treatment of AATD. New data for KRRO-110 shows approximately 60% editing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.